AzTrials
AzTrials

Class II MalocclusionMACTWinNCT07404696

Comparison of Early Interceptive Orthodontic Appliances (Traditional and Novel) and Later Fixed Appliance Treatment in Class II Malocclusion.

A study testing Head gear activator, Twin Block and Invisalign mandibular advancement in people with Class II Malocclusion and Class II Malocclusion, Division 1, run by Vastra Gotaland Region at 3 sites in Sweden.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Background Approximately 15% of children have a Class II malocclusion, where the maxilla is positioned anterior to the mandible, and around 90% of these children also present with an increased overjet. Read more about this study

Who is it for?
Ages 9 to 13 years
What is being tested?
Head gear activator, Twin Block and Invisalign mandibular advancement
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
144 participants
Where
3 sitesSweden
Study dates
15 Jan 2026to 1 Mar 2031
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children age 9-13 years at the start of the trial
  • Mixed dentition, DS3M1
  • Excessive overjet ≥6 mm
  • First permanent molars in at least half cusp Cl II relation bilaterally
  • Incomplete lip closure

Who cannot join

  • Treatment needing extractions due to severe crowding
  • Earlier orthodontic treatment
  • Mouth breathing
  • Ongoing sucking habits
  • Syndromic patients

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Sara Waldenström, PhD student contact

+46768522129

sara.waldenstrom@regionhalland.se

Anna Westerlund, Professor contact

+46317866877

anna.westerlund@odontologi.gu.se

Sweden3 sites
  • Sahlgrenska Academy

    Gothenburg, 40530

  • Orthodontic Specialist Clinic

    Halmstad, 30246

  • Orthodontic Specialist Clinic

    Kungsbacka, 43441

Other trials in Sweden

About this study

Official title: Early Interceptive (Headgear-Activator, Twin Block, Invisalign MA) Versus Later Fixed Appliance Treatment in Class II Malocclusion: A Randomized Clinical Trial

Background Approximately 15% of children have a Class II malocclusion, where the maxilla is positioned anterior to the mandible, and around 90% of these children also present with an increased overjet. Increased overjet is associated with a higher risk of dental trauma and psychosocial consequences such as bullying and reduced oral health-related quality of life (OHRQoL).

Functional orthodontic appliances (e.g., headgear-activator and Twin-block) have long been used to reduce overjet through dentoalveolar effects and by influencing mandibular position and growth. More recently, digital solutions such as Invisalign's mandibular advancement appliance have been introduced, with potential advantages including improved wear time and simultaneous tooth alignment. However, there is currently limited evidence regarding treatment outcomes, patient experience, and cost-effectiveness of these newer appliances compared with established functional appliances.

Read more

Aim The primary aim is to compare treatment outcomes, patient experience, and cost-effectiveness of interceptive orthodontic treatment using three different appliances. The overall aim is to determine whether interceptive treatment of Class II malocclusion with large overjet is effective, and if so, which interceptive modality should be preferred.

Study design and setting

A total of 144 patients aged 9-13 years with Class II malocclusion and large overjet will be randomized into four groups:

  • Headgear-activator
  • Twin-block
  • Aligner Mandibular advancement
  • Control

Participants will be treated at four Orthodontic Specialist Clinics within the National Health Service in Region Halland and Västra Götaland, Sweden. Treatments will be provided by two experienced orthodontic specialists.

Follow-up and data collection

Clinical examinations will be performed at:

  • Baseline (T0)
  • 9 months into treatment (T1)
  • End of treatment (T2) Appliance checks will occur every 8 weeks. Digital scans of the occlusion will be collected at T0, T1, and T2. Lateral cephalometric radiographs will be taken at T0 and T2.

Outcomes and planned analyses

The trial will generate three studies with distinct outcomes:

  1. Treatment outcomes Primary outcome: dental treatment effectiveness measured as overjet reduction. Secondary outcomes: other dental variables, skeletal outcomes, and extraoral outcomes.
  2. Patient-reported outcomes All treated patients will complete two digital questionnaires:
  • Child Perception Questionnaire (CPQ): assesses the child's perception of their teeth before and after treatment.
  • Orthodontic Treatment Impact Questionnaire (OTIQ): assesses the child's experience of orthodontic treatment and the appliance. These outcomes will be used to evaluate changes in OHRQoL from pre- to post-treatment and to compare experiences across treatment modalities.
  1. Cost-effectiveness analysis The economic evaluation will include direct, indirect, and societal costs. Treatment duration, number and length of appointments, and cancellations/no-shows will be recorded.
  • Direct costs: premises, staff salaries, materials, and laboratory costs.
  • Indirect costs: parental loss of income due to absence from work.
  • Societal costs: direct + indirect costs. Costs will be related to treatment outcomes to estimate cost-effectiveness across the treatment arms.

Additional comparison: early vs late treatment Furthermore, after completing 18 months the control group, and half of the functional appliance patients will receive treatment with fixed appliances. This enables an additional comparison of early interceptive treatment versus later treatment using the same outcomes: treatment effectiveness, patient-reported outcomes, and cost-effectiveness.

Being tested
Head gear activator, Twin Block, Invisalign mandibular advancement, Fixed appliance
Medical subject headings
Overbite, Malocclusion, Angle Class II

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Head gear activatorDevice

    Activator with extra orala head gear traction

  • Twin BlockDevice

    Twin Block orthodontic appliance

  • Invisalign mandibular advancementDevice

    Invisalign mandibular advancement featuring occlusal blocks

  • Fixed applianceDevice

    Fixed appliance in upper and lower jaw

Study groups in NCT07404696
Study groupRoleWhat they receive
Head gear activatorExperimentalTreatment with head gear activator orthodontic appliance.
Receives: Device: Head gear activator
Twin BlockExperimentalTreatment with Twin Block appliance
Receives: Device: Twin Block
Invisalign Mandibular AdvancementExperimentalTreatment with Invisalign mandibular advancement featuring occlusal blocks.
Receives: Device: Invisalign mandibular advancement
Fixed applianceExperimentalParticipants will serve as an observation (no treatment) control group during the trial period for 18 months. After completion of the observation phase, they will receive orthodontic treatment with fixed appliances. Outcomes from this delayed intervention will be compared with the three early intervention groups.
Receives: Device: Fixed appliance

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Part I: Dental treatment result: Overjet reduction

    Change in dental overjet compared to baseline. Unit: millimetres (mm). Direction of effect: Lower post-treatment overjet (i.e. greater reduction from baseline) indicates a better outcome; higher overjet values indicate a worse outcome.

    Measured: 18 months

Secondary outcomes (1)
  1. Part I: Dental treatment result: Sagittal relation, overbite

    Sagittal relationship at the end of treatment, evaluated by both molar and canine relationships. Unit: millimetres (mm).

    Direction of effect:

    Change towards Class I in molar and canine relation compared with baseline is favorable.

    Measured: 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2026
  2. Study start15 Jan 2026 (estimated)
  3. Primary completion1 Mar 2031 (estimated)
  4. Study completion1 Mar 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prospective randomized controlled, investigator-blinded, multicentre clinical trial.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
144 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07404696
Sponsor's protocol ID
RCT: Comparing Class II TX
Acronym
MACTWin
Status last verified
Feb 2026
First submitted
17 Dec 2025
Last updated
11 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Charing individual patient data is not approved in the ethical approval.

Questions about this trial

What is this clinical trial studying?

A study testing Head gear activator, Twin Block and Invisalign mandibular advancement in people with Class II Malocclusion and Class II Malocclusion, Division 1, run by Vastra Gotaland Region at 3 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 11 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sara Waldenström, PhD student (+46768522129, sara.waldenstrom@regionhalland.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Part I: Dental treatment result: Overjet reduction (time frame: 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in